Shawver Laura
ARS Pharmaceuticals, Inc. · Director
Shawver Laura is listed in filings as Director at ARS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 27, 2025, including sale activity. Recent filings connect the profile to ARS Pharmaceuticals, Inc. (SPRY). The current snapshot covers public activity from Jun 24, 2024 to Jun 27, 2025. Reported amounts are shown as $517.8K to $133.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $615k50k shares | SellApr 7, 2025 | $12.30 | -- |